DCGI sends show cause notice to Glenmark over \'false claims\'\, steep pricing of Fabiflu
DCGI sends show cause notice to Glenmark over 'false claims', steep pricing of Fabiflu
The drug controller DCGI said that Glenmark's Fabiflu has been priced too high and is not in the common interest of poor, lower middle class and middle class people of the country